Ovarian carcinoma diagnosis: the clinical impact of 15 years of change

by Kommoss, Stefan, Gilks, C Blake, du Bois, Andreas, Kommoss, Friedrich
Published 2016

Patterns of spread of clear cell ovarian cancer: Case report and case series☆

by Kumar, Aalok, Gilks, C. Blake, Mar, Colin, Santos, Jennifer, Tinker, Anna V.
Published 2013

Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study

by Pérez, Teresa, Makrestsov, Nikita, Garatt, John, Torlakovic, Emina, Gilks, C. Blake, Mallett, Susan
Published 2016

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery

by Chay, Wen Yee, Horlings, Hugo M., Tinker, Anna V., Gelmon, Karen A., Gilks, C.Blake
Published 2015

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

by Kucab, Jill E, Lee, Cathy, Chen, Ching-Shih, Zhu, Jiuxiang, Gilks, C Blake, Cheang, Maggie, Huntsman, David, Yorida, Erika, Emerman, Joanne, Pollak, Michael, Dunn, Sandra E
Published 2005

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

by Rajput, Ashish B., Turbin, Dmitry A., Cheang, Maggie CU, Voduc, David K., Leung, Sam, Gelmon, Karen A., Gilks, C. Blake, Huntsman, David G.
Published 2007

Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

by Boylan, Kristin L. M., Misemer, Benjamin, DeRycke, Melissa S., Andersen, John D., Harrington, Katherine M., Kalloger, Steve E., Gilks, C. Blake, Pambuccian, Stefan E., Skubitz, Amy P. N.
Published 2011

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

by Milne, Katy, Alexander, Cheryl, Webb, John R, Sun, Winnie, Dillon, Kristy, Kalloger, Steve E, Gilks, C Blake, Clarke, Blaise, Köbel, Martin, Nelson, Brad H
Published 2012

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

by Milne, Katy, Köbel, Martin, Kalloger, Steven E., Barnes, Rebecca O., Gao, Dongxia, Gilks, C. Blake, Watson, Peter H., Nelson, Brad H.
Published 2013

The cell surface mucin podocalyxin regulates collective breast tumor budding

by Graves, Marcia L., Cipollone, Jane A., Austin, Pamela, Bell, Erin M., Nielsen, Julie S., Gilks, C. Blake, McNagny, Kelly M., Roskelley, Calvin D.
Published 2016

Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers

by Gleicher, Norbert, McAlpine, Jessica N., Gilks, C. Blake, Kushnir, Vitaly A., Lee, Ho-Joon, Wu, Yan-Guang, Lazzaroni-Tealdi, Emanuela, Barad, David H.
Published 2014

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

by Prentice, Leah M, Klausen, Christian, Kalloger, Steve, Köbel, Martin, McKinney, Steven, Santos, Jennifer L, Kenney, Challayne, Mehl, Erika, Gilks, C Blake, Leung, Peter, Swenerton, Ken, Huntsman, David G, Aparicio, Samuel AJ
Published 2007

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

by Press, Joshua Z, De Luca, Alessandro, Boyd, Niki, Young, Sean, Troussard, Armelle, Ridge, Yolanda, Kaurah, Pardeep, Kalloger, Steve E, Blood, Katherine A, Smith, Margaret, Spellman, Paul T, Wang, Yuker, Miller, Dianne M, Horsman, Doug, Faham, Malek, Gilks, C Blake, Gray, Joe, Huntsman, David G
Published 2008

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

by Stany, Michael P., Vathipadiekal, Vinod, Ozbun, Laurent, Stone, Rebecca L., Mok, Samuel C., Xue, Hui, Kagami, Takashi, Wang, Yuwei, McAlpine, Jessica N., Bowtell, David, Gout, Peter W., Miller, Dianne M., Gilks, C. Blake, Huntsman, David G., Ellard, Susan L., Wang, Yu-Zhuo, Vivas-Mejia, Pablo, Lopez-Berestein, Gabriel, Sood, Anil K., Birrer, Michael J.
Published 2011

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing

by Köbel, Martin, Rahimi, Kurosh, Rambau, Peter F., Naugler, Christopher, Le Page, Cécile, Meunier, Liliane, de Ladurantaye, Manon, Lee, Sandra, Leung, Samuel, Goode, Ellen L., Ramus, Susan J., Carlson, Joseph W., Li, Xiaodong, Ewanowich, Carol A., Kelemen, Linda E., Vanderhyden, Barbara, Provencher, Diane, Huntsman, David, Lee, Cheng-Han, Gilks, C. Blake, Mes Masson, Anne-Marie
Published 2016

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

by Harrington, Brittney S, He, Yaowu, Davies, Claire M, Wallace, Sarah J, Adams, Mark N, Beaven, Elizabeth A, Roche, Deborah K, Kennedy, Catherine, Chetty, Naven P, Crandon, Alexander J, Flatley, Christopher, Oliveira, Niara B, Shannon, Catherine M, deFazio, Anna, Tinker, Anna V, Gilks, C Blake, Gabrielli, Brian, Brennan, Donal J, Coward, Jermaine I, Armes, Jane E, Perrin, Lewis C, Hooper, John D
Published 2016

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

by Hunter, Sally M., Anglesio, Michael S., Ryland, Georgina L., Sharma, Raghwa, Chiew, Yoke-Eng, Rowley, Simone M., Doyle, Maria A., Li, Jason, Gilks, C. Blake, Moss, Phillip, Allan, Prue E., Stephens, Andrew N., Huntsman, David G., deFazio, Anna, Bowtell, David D., Gorringe, Kylie L., Campbell, Ian G.
Published 2015

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

by Karnezis, Anthony N, Wang, Yemin, Ramos, Pilar, Hendricks, William PD, Oliva, Esther, D'Angelo, Emanuela, Prat, Jaime, Nucci, Marisa R, Nielsen, Torsten O, Chow, Christine, Leung, Samuel, Kommoss, Friedrich, Kommoss, Stefan, Silva, Annacarolina, Ronnett, Brigitte M, Rabban, Joseph T, Bowtell, David D, Weissman, Bernard E, Trent, Jeffrey M, Gilks, C Blake, Huntsman, David G
Published 2015